









市場
/
株式
/
nasdaq-vrax
/

Virax Biolabs Group Ltd

VRAX

0.628USD

-0.016-2.44%

終値 09/19, 16:00（ET）15分遅れの株価

2.73M時価総額

--直近12ヶ月PER



Virax Biolabs Group Ltd

0.628

-0.016-2.44%

概要企業名金融分析

Virax Biolabs Group Limited is a biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. The Company is engaged in developing a T-Cell Test technologies with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against global viral threats. Its product portfolio includes ViraxClear and Virax Immune. ViraxClear offers a range of accurate diagnostic testing kits and machines. Virax Immune is a new Covid-19 test seeking detection of T-Cell immune responses to the SARS-Cov-2 virus. Its T-Cell testing is effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Monkeypox, Hepatitis B, Malaria, Herpes and Human Papillomavirus.

企業情報

企業コードVRAX

会社名Virax Biolabs Group Ltd

上場日Jul 14, 2022

最高経営責任者「CEO」Mr. James Foster

従業員数19

証券種類Ordinary Share

決算期末Jul 14

本社所在地Biocity Glasgow

都市LONDON

証券取引所NASDAQ Capital Market Consolidated

国United Kingdom

郵便番号ML1 5UH

電話番号4402077887414

ウェブサイトhttps://www.viraxbiolabs.com

企業コードVRAX

上場日Jul 14, 2022

最高経営責任者「CEO」Mr. James Foster

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. James Foster

Chairman of the Board, Chief Executive Officer, Principal Accounting Officer, Co-Founder

368.57K

+27.98%

Mr. Evan Norton

Independent Director

15.33K

Dr. Iain Miller

Independent Director

Mr. Nelson M. Haight

Independent Director

Dr. Nigel Mccracken, Ph.D.

Chief Operating Officer, Director

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. James Foster

Chairman of the Board, Chief Executive Officer, Principal Accounting Officer, Co-Founder

368.57K

+27.98%

Mr. Evan Norton

Independent Director

15.33K

Dr. Iain Miller

Independent Director

Mr. Nelson M. Haight

Independent Director

Dr. Nigel Mccracken, Ph.D.

Chief Operating Officer, Director

収益内訳

データなし

データなし

事業別

地域別

データなし

株主

更新時刻: Tue, Aug 19

株主統計

種類

株主統計

比率

Foster (James)

8.49%

Armistice Capital LLC

5.25%

Citadel Advisors LLC

0.69%

Mccracken (Nigel Ph.D.)

0.54%

Norton (Evan)

0.35%

他の

84.67%

株主統計

比率

Foster (James)

8.49%

Armistice Capital LLC

5.25%

Citadel Advisors LLC

0.69%

Mccracken (Nigel Ph.D.)

0.54%

Norton (Evan)

0.35%

他の

84.67%

種類

株主統計

比率

Individual Investor

10.09%

Hedge Fund

5.95%

Bank and Trust

0.12%

他の

83.85%

機関投資家保有株

更新時刻: Tue, Jul 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q2

729.04K

16.79%

+148.45K

2025Q1

579.67K

13.35%

-10.90K

2024Q4

579.58K

13.35%

-22.54K

2024Q3

734.94K

16.93%

+329.85K

2024Q2

359.31K

9.40%

-99.69K

2024Q1

305.99K

7.33%

-151.07K

2023Q4

422.04K

26.02%

+96.63K

2023Q3

636.78K

40.92%

-179.86K

2023Q2

639.17K

41.06%

-174.53K

2023Q1

797.76K

51.31%

+134.82K

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

Foster (James)

368.57K

8.49%

+80.58K

+27.98%

Mar 31, 2025

Armistice Capital LLC

228.04K

5.25%

+228.04K

Sep 30, 2024

Citadel Advisors LLC

13.54K

0.31%

+13.54K

Mar 31, 2025

Mccracken (Nigel Ph.D.)

23.33K

0.54%

+23.33K

Mar 31, 2025

Norton (Evan)

15.33K

0.35%

+15.33K

Mar 31, 2025

Erez (Yair)

15.33K

0.35%

+15.33K

Mar 31, 2025

Haight (Nelson)

15.33K

0.35%

+15.33K

Mar 31, 2025

UBS Financial Services, Inc.

22.43K

0.52%

-15.49K

-40.85%

Mar 31, 2025

RBC Dominion Securities, Inc.

-10.40K

-100.00%

Mar 31, 2025

詳細を見る